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Taspase1: A Threonine Aspartase Required
for Cleavage of MLL
and Proper HOX Gene Expression
kemias bearing MLL translocations identified a charac-
teristic gene expression profile that distinguishes this
poor prognosis leukemia from other leukemias (Arm-
strong et al., 2002; Yeoh et al., 2002). Among the upregu-
lated genes were some recognized targets of MLL in-
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Boston, Massachusetts 02115 cluding select HOX genes. Deregulated expression of
HOX genes typifies certain malignancies (Buske and
Humphries, 2000; Cillo et al., 2001; Dash and Gilliland,
2001).Summary
Recently, we and others demonstrated that MLL is
normally processed at two cleavage sites CS1 (D/GADD)The Mixed-Lineage Leukemia gene (MLL/HRX/ALL1)
encodes a large nuclear protein homologous to Dro- and CS2 (D/GVDD) and that mutation of both sites abol-
ishes the proteolysis (Hsieh et al., 2003; Yokoyama etsophila trithorax that is required for the maintenance
of HOX gene expression. MLL is cleaved at two con- al., 2002) (Figure 1B). The sequence of the cleavage
site is highly conserved in MLL homologs from fliesserved sites generating N320 and C180 fragments,
which heterodimerize to stabilize the complex and to mammals. MLL cleavage generates N-terminal p320
(N320) and C-terminal p180 (C180) fragments, whichconfer its subnuclear destination. Here, we purify and
clone the protease responsible for cleaving MLL. We heterodimerize to form a stable complex that localizes to
a subnuclear compartment. The FYRN domain of N320entitle it Taspase1 as it initiates a class of endopepti-
dases that utilize an N-terminal threonine as the active directly interacts with the FYRC and SET domains of
C180. This dynamic postcleavage association conferssite nucleophile to proteolyze polypeptide substrates
following aspartate. Taspase1 proenzyme is intra- stability to N320 and correct nuclear sublocalization of
the MLL complex for proper target gene expressionmolecularly proteolyzed generating an active 28 kDa
/22 kDa  heterodimer. RNAi-mediated knockdown (Hsieh et al., 2003).
Site-specific proteolysis is essential in many impor-of Taspase1 results in the appearance of unprocessed
MLL and the loss of proper HOX gene expression. tant biological pathways including the sequential activa-
tion of blood coagulation factors (Furie and Furie, 1992),Taspase1 coevolved with MLL/trithorax as Arthropoda
and Chordata emerged from Metazoa suggesting that cholesterol-gauged liberation of SREBP from the ER
(Brown et al., 2000), ligand-activated cleavage and sub-Taspase1 originated to regulate complex segmental
body plans in higher organisms. sequent release of the intracellular domain of Notch
(Brown et al., 2000), maturation of the hedgehog-signal-
ing molecule (Ye and Fortini, 2000), separation of HCF-1Introduction
for proper cell cycle regulation (Wilson et al., 1995), and
activation of caspases and their subsequent cleavageMLL/HRX/ALL1 encodes a 3969 amino acid nuclear pro-
tein bearing multiple conserved domains with assigned of death substrates during apoptosis (Thornberry and
Lazebnik, 1998). Identification and characterization ofactivities including an N terminus with three AT-hook
motifs that bind AT rich DNA segments (Zeleznik-Le et the responsible proteases has not only proven critical
to understanding such biologic processes but also foral., 1994), a DNA methyl transferase homology domain
that represses transcription (Xia et al., 2003), four PHD developing targeted therapeutics for diseases involving
specific pathways. To better understand the regulationfingers that mediate protein-protein interactions (Fair et
al., 2001), a transactivation domain that interacts with of MLL cleavage and hence its effects on target gene
expression, we purified the protease responsible forCBP (Ernst et al., 2001), and a C-terminal SET domain
with histone H3 lysine 4 methyl transferase activity MLL cleavage.
(Milne et al., 2002; Nakamura et al., 2002) (Figure 1A).
MLL and its Drosophila homolog trithorax are required Results
for maintaining proper Hox and homeotic gene expres-
sion patterns, respectively (Breen and Harte, 1993; Yu Site Specific MLL Cleavage Substrate
et al., 1998). Inhibitors to the known classes of proteases showed no
Chromosome translocations characteristically found substantial inhibition of MLL processing within whole
in human infant leukemia disrupt MLL (11q23), generat- cells, providing the first suggestion that this cleavage
ing chimeric proteins between the MLL N terminus and activity would prove unique. To facilitate the character-
multiple translocation partners that vary substantially ization of the MLL protease, we generated a tractable
(Ayton and Cleary, 2001; Domer et al., 1993; Downing cleavage substrate. We found that aa 2400–2900 of MLL
and Look, 1996; Gu et al., 1992; Thirman et al., 1993; containing CS1 (aa 2666) and CS2 (aa 2718) are sufficient
Tkachuk et al., 1992). Mice carrying engineered Mll to recapitulate endogenous MLL cleavage (Figure 1C).
translocations develop leukemia (Corral et al., 1996; For- Proteolysis of this p75 MLL test substrate at CS1 or
ster et al., 2003). Gene expression profiles of infant leu- CS2 would generate N-terminal Myc-tagged p42 or p47
fragments and C-terminal Flag-tagged p33 or p28, re-
spectively (Figure 1A). The p47 and p28 fragments were*Correspondence: stanley_korsmeyer@dfci.harvard.edu
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Figure 1. A Cleavage-Site Reporter for MLL Proteolysis
(A) Conserved domain structure of human MLL with cleavage sites (CS1 and CS2). Predicted N-terminal and C-terminal tagged proteolytic
products of a 75 kDa wt MLL fragment spanning aa 2400–2900.
(B) Conservation of CS1 (D/GADD) and CS2 (D/GVDD) among MLL family members.
(C) Doubly tagged p75 MLL reporter fragments were transfected into 293T cells and proteolysis by endogenous protease assessed by anti-
Myc (left image) or anti-Flag (right image) Western blots. The p47 and p28 cleaved products of wt p75 MLL were most abundant, indicating
a preference for CS2 over CS1. The mutant p75 MLL (CS1/2 mt) bearing CS1 (DG2666AA) and CS2 (DGV2718AAA) sequences was not cleaved.
most abundant, indicating processing at CS2 is more embryonic kidney cell line) were incubated with in vitro
transcribed/translated 35S-methionine-labeled p75 MLLefficient than at CS1. This is consistent with our prior
observations of the proteolysis of full-length MLL protein substrates. The light membrane (LM) fraction displayed
the most enzymatic activity (Figure 2A, left image) and(Hsieh et al., 2003). The transfected p75 MLL substrate
with mutant CS1/CS2 sites (CS1/2 mt) was not cleaved did not cleave the mutant fragment (CS1/2 mt) (Figure
2A, right image). Inhibitors of multiple classes of prote-indicating the specificity of this substrate (Figure 1C).
Subcellular fractions derived from 293T cells (a human ases including serine proteases, cysteine proteases,
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Figure 2. In Vitro Reconstitution of MLL Cleavage Using Subcellular Fractions
(A) The light membrane (LM) subcellular fraction of 293T cells contains enzymatic activity that cleaves the wt but not mutant (CS1/2 mt) p75
MLL reporter, judged by the appearance of p47 and p28 fragments. Lower level activity also exists in the S100 cytosolic fraction.
(B) None of the tested protease inhibitors affected the MLL cleavage activity in the LM fraction. 35S-methionine-labeled in vitro transcribed/
translated p75 MLL substrates were incubated with indicated subcellular fractions and the proteolysis of the reporter fragment analyzed by
SDS-PAGE followed by autoradiography.
metalloproteases, acid proteases, and the 26S protea- tivity followed by an in vitro cleavage assay. Seven chro-
matographic steps achieved an approximately 200,000-some, were examined but again showed no substantial
inhibition of MLL proteolysis in this fraction enriched for fold enrichment of the proteolytic activity (Figure 3A).
The ultimate mono S fractions displaying the highestendoplasmic reticulum (Figure 2B). Only heat incubation
at 70C for 30 min inactivated the proteolytic activity in enzymatic activity were subjected to SDS-PAGE fol-
lowed by a silver stain (Figure 3B). Polypeptide bandslight membranes.
whose presence best correlated with the proteolytic ac-
tivity were digested with trypsin and subjected to liquidPurification
The LM fraction possessing the protease activity was chromatography and tandem mass spectrometry (LC-
MS/MS) sequence analysis. Two peptide sequencessubjected to serial column chromatography and the ac-
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Figure 3. Purification and Cloning of the MLL Cleaving Protease, Taspase1
(A) Schematic of the seven chromatographic steps utilized to enrich the MLL cleaving protease. The enzymatic activity was followed by the
in vitro cleavage assay (Figure 2).
(B) Silver-stained SDS-PAGE of the mono S fraction with maximum enzymatic activity. The asterisks denote two peptide sequences obtained
from a 28 kDa band whose abundance correlated with enzyme activity (arrow).
(C) Alignment of active sites among Asparaginase_2 family proteins recognizes three distinct conserved motifs that distinguish the Taspase1,
glycosylasparaginase and L-asparaginase subfamilies. Conserved active site threonine nucleophiles indicated by asterisks.
(D) Taspase1 was doubly tagged and transiently expressed in 293T cells. Taspase1 is processed from a 50 kDa precursor to an N-terminal
28 kDa  and a C-terminal 22 kDa  subunit in 293T cells (lane 2, both images). Substitution of either aspartate 233 (D233A) or threonine 234
(T234A) with alanine abolished the processing of the Taspase1 proenzyme (lanes 3 and 4, both images).
corresponding to aa 124–137 and aa 138–145 of an un- that migrated at28 kDa (Figure 3B). The orf predicts a
420 aa protein possessing an Asparaginase_2 homologycharacterized open reading frame (orf) present on chro-
mosome 20 (c20orf13) were identified from a gel slice domain (pfam 01112, interpro 000246) from aa 41–391
Tapsase1 Cleaves MLL
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Figure 4. Cleavage of MLL Substrate by Re-
combinant Taspase1
(A) Purified recombinant Taspase1 (rTas-
pase1) at 100 ng processes 35S-methionine-
labeled p75 wt MLL substrate (left image) but
not p75 CS1/2 mt substrate (right image).
Taspase1 processed p75 more completely
than the final mono S fraction utilized in Fig-
ure 3B (lane 2 and 3, left image).
(B) Taspase1 sequential cleavage of CS1 and
CS2. 35S-methionine labeled p75 wt MLL sub-
strate was incubated with 1 ng or 10 ng rTas-
pase1 at a final volume of 25 l and samples
were analyzed over time by SDS-PAGE and
autoradiography for cleavage. The more con-
served CS2 was cleaved (p47 fragment) be-
fore CS1 (p47 fragment) at 1 ng rTaspase1
(upper image). 10-fold more rTaspase1 (10
ng) increased CS1 processing (lower image).
(Figure 3C). Typical proteins that contain this signature The p42 fragment results from cleavage at the CS1
(D/GADD) site, which is less conserved than CS2 (D/GVDD)motif include L-asparaginase and glycosylasparaginase
(Figure 3C). L-asparaginase catalyzes an amide bond and is also less efficiently processed in vivo (Hsieh et
al., 2003). We next examined the differential sensitivityhydrolysis to convert L-asparagine to L-aspartate. Gly-
cosylasparaginase is an amidohydrolase, which cata- of CS1 and CS2 sites for cleavage by rTaspase1. The
p47 fragment appears first, while higher enzyme con-lyzes the N-acetylglucosamine-asparagine bond that
links oligosaccharides to asparagine. However, no en- centration or more time is needed for the appearance
of the p42 fragment indicating a preference of rTaspase1dopeptidase activity had been demonstrated to date
among the Asparaginase_2 family enzymes. The charac- for CS2 over CS1 (Figure 4B). Thus, the cloned Tas-
pase1’s proteolytic characteristics match the pattern ofteristics of this MLL cleaving protease (c20orf13) as sub-
sequently detailed here prompt its designation as Tas- endogenous MLL proteolysis.
pase1 (Threonine aspartase1). Sequence alignment
searches of the public databases identified highly con- The First Threonine Aspartase, Taspase1
Purification of recombinant N-terminal His-tagged Tas-served Taspase1 orthologs in fly, mosquito, pufferfish,
zebrafish, rat, mouse, and human (Figure 3C, Supple- pase1 yielded an expected 50 kDa product, a His-tagged
28 kDa  subunit, and a copurified 22 kDa polypeptidemental Figure S1 available at http://www.cell.com/cgi/
content/full/115/3/293/DC1), but not in the nematode, (Figure 5A). This 22 kDa polypeptide was subjected to
N-terminal Edman degradation analysis, which identi-C. elegans. The conserved LDTVG motif that surrounds
a putative threonine active site is distinct from L-aspara- fied threonine 234 of Taspase1 as the N-terminal amino
acid of the apparent 22 kDa  subunit (Figure 5A). Thisginase and glycosylasparaginase (Figure 3C) suggesting
it may have a unique specificity. represents proteolysis between aspartate 233 and thre-
onine 234 of the 50 kDa putative proenzyme. Similarly
when an N-terminal and C-terminal epitope tagged hu-Recombinant Taspase1 Activity
To assess the potential activity of this candidate prote- man Taspase1 cDNA was expressed in the human 293
T cell line, the 50 kDa product also appeared to bease, we expressed and purified recombinant N-terminal
His-tagged Taspase1 from E. coli. Recombinant Tas- processed to a 28 kDa N-terminal  subunit and a 22
kDa C-terminal  subunit (Figure 3D). This suggestedpase1 (rTaspase1) cleaved the wt p75 MLL but not the
CS1/2 mt substrate (Figure 4A). rTaspase1 more effi- that Taspase1 may be intramolecularly proteolyzed and
processed subunits reassembled through a noncovalentciently processed p75 MLL to completion based on the
predominance of the p42 fragment when compared to association. Amino acid substitution of either aspartate
233 (D233A) or threonine 234 (T234A) to alanine eachthe activity in the original mono S fraction (Figure 4A).
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Figure 5. Taspase1 Proenzyme Undergoes
Intramolecular Processing to an Active 28
kDa /22 kDa  Heterodimer
(A) Cobalt column purification of bacterial-
expressed, N-terminal His-tagged wt and
mutant Taspase1. A 22 kDa fragment copuri-
fied with the His-tagged 28 kDa  subunit of
Taspase1 (lane 1). Edman degradation of the
22 kDa fragment revealed a 14 amino acid
sequence of Taspase1 beginning at threonine
234 (asterisk), which proved to be the 22 kDa
 subunit that heterodimerizes with His-28.
Anti-His tag Ab recognized both the 50 kDa
His-proenzyme and the processed His-28
but not the processed 22 of rTaspase1 (data
not shown). Alanine substitutions of aspar-
tate 233 (D233A) or threonine 234 (T234A)
abolish the intramolecular proteolysis of Tas-
pase1 (lanes 2 and 3).
(B) Purified rTaspase1 in a dose-response
assay cleaves 35S-methionine-labeled p75 wt
MLL substrate. The D233A mutant rTaspase1
(middle image) demonstrated an 1,000-fold
decrease in MLL proteolysis. The T234A mu-
tant rTaspase1 demonstrated no enzymatic
activity consistent with T234 being the active
site nucleophile (lower image).
abolished the intramolecular processing of Taspase1 Taspase1, but not the T234A mutant of the nucleophile
site demonstrated intramolecular processing into /expressed in E. coli (Figure 5A) or in mammalian cells
(Figure 3D). However, the D233A mutant retained some fragments (Figures 3D and 6A). To assess the role of
endogenous Taspase1, we designed duplex RNAiresidual enzymatic activity, although it was 1000-fold
less efficient than the wt enzyme (Figure 5B, middle against Taspase1, which knocked down the expression
of endogenous Taspase1 by 80% in HeLa cells (Fig-image). Conversely, threonine 234 which became the
N terminus of the  subunit is absolutely essential for ures 6B and 6C). This reduction of endogenous Tas-
pase1 severely impaired the cleavage of transfected p75cleavage activity (Figure 5B, lower image). These enzy-
matic characteristics are similar to properties shared by wt MLL reporter as judged by the marked decrease in
the processed p47 fragment (11  3% of control RNAi;L-asparaginase and glycosylasparaginase which also
demonstrate autoproteolysis of a proenzyme into an n  3 experiments; p  0.005) and the disappearance
of the p42 fragment (Figure 6B). Taspase1 RNAi knock-active/ heterodimeric enzyme in which the N-terminal
threonine of the  subunit is the active site nucleophile down also resulted in a 50% decrease in the endoge-
nous, processed C180 MLL fragment as well as an in-for catalysis (Guan et al., 1996; Liu et al., 1998; Tikkanen
et al., 1996; Xu et al., 1999). Thus, to our knowledge, this creased abundance of full-length p500 MLL (4.3-fold
increase over control RNAi; n  3 experiments; p MLL cleaving protease is the only known endopeptidase
within the Asparaginase_2 family with the characteristic 0.005) (Figure 6C). In contrast, MLL RNAi resulted in the
marked reduction of the C180 MLL fragment, but didof being a threonine aspartase, Taspase1.
not increase p500 MLL (Figure 6C). In total, both the in
vitro and in vivo cleavage assays confirm the role ofProteolysis of MLL In Vivo Requires Taspase1
Taspase1 in the proper processing of MLL.We next asked whether Taspase1 was required to cleave
MLL within mammalian cells. As a model system to test
specificity, we coexpressed the p75 MLL substrate re- Taspase1 Is Required for Proper HOX
Gene Expressionporter together with Taspase1 in 293T cells. Taspase1
resulted in cleavage of wt p75 MLL but not the p75 CS1/2 Genetic studies in both mice and flies establish that Mll
and trithorax regulate Hox and homeotic gene expres-mt reporter (Figure 6A). Wt Taspase1, but not the T234A
mutant Taspase1, enhanced the processing of p75 MLL sion, respectively (Mazo et al., 1990; Yu et al., 1995).
Mice heterozygous for an Mll-exon3LacZ disruption dem-to the final p42 product (Figures 1A and 6A). Only wt
Tapsase1 Cleaves MLL
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Figure 6. Taspase1 Is Required for Endogenous MLL Cleavage and Proper HOX Gene Regulation
(A) Constructs expressing wt or mt p75 MLL substrate (as in Figure 1C) were cotransfected with wt or mt (T234A) Taspase1 bearing an
N-terminal protein-C tag into 293T cells. The N-terminal cleavage products of p75 MLL were detected by an anti-Myc Western blot. The
cleavage of wt p75 MLL substrate by endogenous protease is shown in lane 1, upper image. Transfection of wt Taspase1 enhanced complete
processing of p75 MLL processing, judged by the decrease of both p75 and p47, and the increase of the p42 fragment (lanes 2, upper image).
No enhancement was observed with transfected T234A mutant (lane 3, upper image). The intramolecular proteolysis of expressed wt but not
the T234A mutant Taspase1 is demonstrated by antiprotein C Western blot (lower image).
(B) RNAi-mediated knockdown of endogenous Taspase1 impairs the processing of p75 wt MLL. HeLa cells were treated with indicated duplex
RNAi for 48 hr before introduction of the p75 wt MLL expression construct and analysis of cleavage 24 hr later. Taspase1 knockdown leads
to a marked decrease in the p47 and the disappearance of the p42 fragment (lane 2).
(C) RNAi-mediated knockdown of endogenous Taspase1 results in increased abundance of unprocessed p500 MLL and diminished processed
C180 MLL (lane 2). The indicated duplex RNAi was introduced into HeLa cells and the expression of Taspase1 28, p500 MLL, C180 MLL,
and actin were detected by the respective Abs. MLL RNAi markedly reduced the expression C180 MLL (lane 3). Control duplex RNAi had no
effect (lane 1).
(D) Altered HOX A gene expression in Taspase1 knockdown cells. Quantitative RT-PCR analysis of indicated gene expression of RNAi-treated
HeLa cells is shown as a bar graph. The expression of individual genes is normalized to GAPDH levels for individual samples. The %
expression of an indicated gene is calculated in comparison to a control duplex RNAi set at 100%. Values shown are mean  1 SD of four
independent experiments.
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Figure 7. A Schematic Model Depicts the Intramolecular Proteolysis of Taspase1 Followed by MLL Processing Required for Proper HOX
Gene Expression
onstrate haploinsufficiency with bidirectional homeotic the ordered degradation of N-linked glycoproteins by
cleaving Asn-GlcNAc linkages that join oligosaccha-transformations and shifted anterior boundaries of sev-
eral Hox genes (Yu et al., 1995). Mll/ deficient embryos rides to proteins. Taspase1-mediated cleavage of MLL
follows distinct aspartate residues suggesting Taspase1and mouse embryonic fibroblasts (MEFs) demonstrate
Mll is required for the maintenance of selected Hox gene evolved from hydrolyzing asparagine and glycosylaspara-
gine to recognize a conserved peptide motif with anexpression (Hanson et al., 1999; Yu et al., 1995, 1998).
As a first assessment of whether reduced Taspase1 aspartate at the P1 position. Taspase1 also belongs to
a larger superfamily of diverse enzymes that are Ntn-activity would alter gene expression, we examined the
gene expression profile of HeLa cells treated with the hydrolases (N-terminal nucleophiles) (Brannigan et al.,
1995). All members of this family are activated autocata-Taspase1 RNAi versus a control RNAi (Figure 6D). Initial
analysis of Affymetrix (HG-U133A) oligonucleotide array- lytically, displaying an N terminally located catalytic nu-
cleophile. The nascent single polypeptide is cleaved intobased RNA profiles indicated diminished expression of
selected HOX genes (data not shown). Consequently, nonidentical  and  subunits, which assemble into a
catalytically active  heterodimeric structure (Oino-we used a quantitative RT-PCR approach to determine
the relative expression of genes across the HOX A clus- nen and Rouvinen, 2000). Glycosylasparaginase is a
well-characterized prototype that self-catalyses a pep-ter. Of note, the knockdown of Taspase1 diminished the
expression of the 3	 located and “earlier” expressed tide bond rearrangement. Of note, the threonine that
provides the nucleophile for both autoproteolysis andgenes in the HOX A cluster (A1, A3, and A4), but not
those genes located more 5	 and expressed “later” dur- hydrolase activity as well as the immediately upstream
aspartate residue are conserved in Taspase1. The threo-ing embryonic development (A5, A9, and A10) (Figure
6D). This selected attenuation contrasts with the global nine nucleophile of glycosylasparaginase appears to at-
tack this immediately upstream amide bond through andecrease in expression of most HOX A genes (A1 to
A10) in cells with MLL knocked down (Figure 6D). These N-
O acyl shift to catalyze this peptide bond cleavage
(Xu et al., 1999). In the Ntn-hydrolase superfamily thedata support the importance of Taspase1 in the correct
expression of the early HOX A gene cluster (equivalent to nucleophile always originates from the N terminus of
the  subunit. The complete dependence of Taspase1the ANT-C cluster of Drosophila) (Figure 7).
upon thr234 for both its intramolecular proteolysis to
generate an / heterodimer as well as its proteolyticDiscussion
activity for MLL substrates supports its role as the active
nucleophile and the inclusion of Taspase1 in this family.We utilized highly conserved cleavage sequences within
MLL to purify and clone a novel protease responsible Caspases and Granzyme B are well-characterized
proteases that also cleave peptide bonds after a P1for the routine proteolysis of MLL. Taspase1 (threonine
aspartase 1) is an endopeptidase within a family of en- aspartate (Odake et al., 1991; Thornberry et al., 1992).
However, they belong to structurally distinct, large fami-zymes possessing an Asparaginase_2 homology do-
main. Other members present in both prokaryotes and lies of proteases that use cysteine or serine as the active
nucleophile. Among the known proteases, the  subuniteukaryotes include the amidohydrolases, L-asparagi-
nase in intermediary amino acid metabolism and glyco- of the 20S proteasome, the  subunit of the archea
proteasome, and the catalytic subunit of E. coli HslV aresylasparaginase. Glycosylasparaginase participates in
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known threonine endopeptidases (Bochtler et al., 1999; 1998). Mll loss-of-function studies indicate it is required
Seemuller et al., 1995). While the 20S proteasome may for maintaining Hox expression during early embryogen-
be responsible for site-specific cleavage of precursor esis (Yu et al., 1995). Moreover, the axial-skeletal trans-
proteins such as p105 NFkB (Palombella et al., 1994), formations and altered Hox patterns of Mll-deficient
it predominantly participates in protein degradation mice were normalized when PcG member Bmi-1 was
(Hochstrasser, 1996). deleted (Hanson et al., 1999). The CS2 (D/GVDD) cleav-
MLL family proteins have architecturally positioned age site in Drosophila TRX resides within a 281aa region
domains with distinct biochemical properties (Figure 1A deleted in a mutant trx allele, trxE3 (Mazo et al., 1990).
and Supplemental Figure S2 available at Cell website). Null mutations of trx fail to maintain the expression of
Vertebrate MLL has two conserved cleavage sites, CS1 homeotic genes of both the bithorax (BX-C) and anten-
and CS2 (Hsieh et al., 2003). Of note, other homologs napedia (ANT-C) complexes (Breen, 1999). Whereas,
including invertebrate trithorax and vertebrate MLL2 trxE3 displays selectively reduced expression of ANT-C
only possess the more conserved CS2 site. These cleav- but not BX-C genes (Sedkov et al., 1994). Subsequent
age sites are strategically positioned such that proteo- studies using antibodies recognizing different regions of
lyzed MLL fragments form a heterodimeric complex uti- TRX support the CS2 sequences serving as a proteolytic
lizing the FYRN domain of N320 and the FYRC plus site (Kuzin et al., 1994). Similarly, our RNAi knockdown
SET domains of the C180 fragment (Hsieh et al., 2003). of Taspase1 in mammalian cells suggests that cleavage
Consequently, the postcleavage reassembly of MLL of MLL is important in maintaining expression of the
fragments would be predicted to bring four domains “early” 3	 located HOX A genes (HOX A1, A3, A4 analo-
(i.e., PHD4, FYRN, FYRC, and SET) in close proximity. gous to ANT-C) but not the “late” more 5	 located HOX
This postcleavage juxtaposition is reminiscent of the A genes (HOX A9, A10 analogous to BX-C) (Figure 7).
contiguous four-domain cluster, PHD4-FYRN-FYRC- In contrast, RNAi knockdown of MLL and our Mll-null
SET, found at the C terminus of more evolutionarily dis- cells display more global defects in Hox gene expression
tant MLL homologs (Supplemental Figure S2 available similar to trx-null alleles (data not shown). Perhaps the
at Cell website). This latter set of proteins is present earliest expressed 3	 HOX genes are most dependent
in all Metazoa including T12D8.1 of C. elegans and trr upon processed MLL, raising the possibility that the
(trithorax-related) of Drosophila, ALR (ALL1 Related) precise multiprotein complexes assembled by MLL
and MLL3 of Homo sapiens (Supplemental Figure S2 might vary along the HOX gene cluster. A role for Tas-
available at Cell website). These proteins with clustered pase1-mediated cleavage of MLL in proper HOX gene
domains do not display the cleavage sequence and re- expression suggests Taspase1 coevolved with MLL/tri-
combinant MLL3 was not proteolyzed (data not shown). thorax at the time when Arthropoda and Chordata
The proximity of these four domains may be essential for emerged from Metazoa, enabling the more complex
a common biochemical property of this protein family. axial skeletal and developmental plans of higher or-
Higher organisms with complex body plans require addi- ganisms.
tional levels of regulation for specification programs in-
cluding those mediated by Hox genes. Chordata and
Experimental Procedures
Arthropoda possess MLL homologs with motifs proteo-
lyzed by the coevolved Taspase1, which distinguishes Plasmid Construction and Antibody Production
them from the more ancient four-domain cluster. PCR fragments consisting of MLL aa 2400–2900 derived from either
wild-type or noncleavable MLL mt (CS1/CS2 mt) were inserted intoDeregulated expression of selected HOX genes ac-
a Myc/Flag doubly tagged eukaryotic expression vector for transientcompanies some human malignancies including leuke-
transfection assays. These constructs also contain a 5	 T7 promotermias bearing chromosomal translocations that result in
for generating in vitro transcription/translation product of 35S-methi-MLL-fusion proteins (Armstrong et al., 2002; Yeoh et al.,
onine-labeled p75 MLL substrates. Full-length Taspase1 was cloned
2002). Recently, the transformation of myeloid progeni- from 293T cell cDNA and inserted into the Myc/Flag doubly tagged
tors mediated by an MLL-ENL fusion protein was shown expression vector, a protein C-tagged vector, and a His-tagged
to depend on selected downstream Hox genes (Ayton bacteria expression vector, ET15b (Novagen). Taspase1 mutants
were generated using QuikChange site-directed mutagenesis kitand Cleary, 2003). The discovery of Taspase1 provides
(Stratagene). Rabbit anti-Taspase1 polyclonal antibody was raiseda unique opportunity to probe the role of MLL cleavage
against aa 7–212 of purified recombinant human Taspase1. Tran-in both physiologic and pathologic settings. Finally, our
sient transfection, in vitro transcription/translation, 35S-methioninedata warrant development of a Taspase1 inhibitor that
labeling, and immunoblot assays were performed as previously de-
would be predicted to impair expression of selected scribed (Hsieh et al., 2003).
HOX genes and might prove a rational approach to can-
cer therapy.
In Vitro Cleavage Assays
Homeotic genes of the invertebrates and Hox genes of 35S-methionine-labeled MLL substrate was incubated with 2 l of
the vertebrates encode a family of related transcription- indicated subcellular fractions or specified amounts of rTaspase1
regulatory proteins that play essential roles in imple- in cleavage buffer (100 mM HEPES [pH 7.9], 5 mM MgCl2, 20 mM
menting developmental patterns and conferring critical KCl, 5 mM DTT, and 10% sucrose) at a final volume of 25 l for 1 hr
at 37C or indicated periods of time. Protease inhibitors utilizedpositional information (Krumlauf, 1994). The initiation of
include 8.5 M phosphoramidon, 100 M TLCK, 100 M TPCK,Hox gene expression is controlled by transiently ex-
5 mM iodoacetamide, 5 mM N-ethylmaleimide, 0.3 M aprotinin,pressed segmentation gene products. However, the
100 M leupeptin, 1 M pepstatin, 1 complete protease inhibitor
maintenance of appropriate Hox expression patterns is cocktail (Roche), 100 M anti-pain, 100 M APMSF, 10 M bestatin,
conferred by the positive regulatory trithorax group (trx-G) 25 M ALLN, 100 M chymostatin, 10 M E-64, 5 mM EDTA, 1 mM
and the negative regulatory polycomb group (Pc-G), PMSF, 1 mM EGTA, 50 M BAF (Boc-Aspartyl-FMK), and 50 M
z-VAD (z-VAD-FMK).which heavily utilize epigenetic mechanisms (Pirrotta,
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Purification and LC-MS/MS Ayton, P.M., and Cleary, M.L. (2003). Transformation of myeloid
progenitors by MLL oncoproteins is dependent on Hoxa7 andHuman 293T cells from one hundred 15 cm dishes were collected
and incubated in hypotonic buffer (10 mM HEPES [pH 7.9], 1.5 mM Hoxa9. Genes Dev. 17, 2298–2307.
MgCl2, 10 mM KCl, 0.2 mM PMSF, 1 mM EDTA, 1 mM EDTA, 1 mM Bochtler, M., Ditzel, L., Groll, M., Hartmann, C., and Huber, R. (1999).
EGTA, and protease inhibitor cocktail [Roche]) for 15 min on ice. The proteasome. Annu. Rev. Biophys. Biomol. Struct. 28, 295–317.
Supplemented protease inhibitors were omitted during the initial
Brannigan, J.A., Dodson, G., Duggleby, H.J., Moody, P.C., Smith,characterization of MLL cleaving protease. Cells were homogenized
J.L., Tomchick, D.R., and Murzin, A.G. (1995). A protein catalyticusing a glass dounce and the homogenized cellular extract was
framework with an N-terminal nucleophile is capable of self-activa-subjected to centrifugal fractionation. Nuclei (Nuc) and unbroken
tion. Nature 378, 416–419.cells were twice separated at 700 g for 10 min. The heavy membrane
Breen, T.R. (1999). Mutant alleles of the Drosophila trithorax gene(HM) fraction pellet was collected after two centrifugations of the
produce common and unusual homeotic and other developmentalsupernatant at 7000 g for 10 min. The resulting supernatant was
phenotypes. Genetics 152, 319–344.centrifuged at 100,000 g for 30 min to yield the light membrane
pellet (LM) and final soluble fraction (S100). Proteins were solubilized Breen, T.R., and Harte, P.J. (1993). Trithorax regulates multiple ho-
in buffer A (20 mM HEPES [pH 7.9], 100 mM KCl, 1.5 mM MgCl2, 0.2 meotic genes in the bithorax and antennapedia complexes and ex-
mM PMSF, 1 mM DTT, 1 mM EDTA, 1 mM EGTA, 0.1% Tween 20, erts different tissue-specific, parasegment-specific and promoter-
and 10% glycerol) with additional 0.5% of Tween 20. Solubilized specific effects on each. Development 117, 119–134.
LM fraction was applied to a P11 column and the bound protease Brown, M.S., Ye, J., Rawson, R.B., and Goldstein, J.L. (2000). Regu-
was eluted with gradients of KCl. Positive fractions were collected lated intramembrane proteolysis: a control mechanism conserved
and dialyzed against buffer B (10 mM HEPES [pH 7.9], 100 mM KCl, from bacteria to humans. Cell 100, 391–398.
1 mM MgCl2, 10 M CaCl2, 0.2 mM PMSF, 1 mM DTT, 1 mM EDTA,
Buske, C., and Humphries, R.K. (2000). Homeobox genes in leuke-1 mM EGTA, 10% glycerol, 0.1% Tween 20, and 10 mM potassium
mogenesis. Int. J. Hematol. 71, 301–308.phosphate [pH 7.9]) and applied to a hydroxyapatite column. Elution
Cillo, C., Cantile, M., Faiella, A., and Boncinelli, E. (2001). Homeoboxwas performed with a phosphate gradient and the protease positive
genes in normal and malignant cells. J. Cell. Physiol. 188, 161–169.fractions were dialyzed against buffer A before loading onto indi-
cated chromatographic columns. LC-MS/MS was performed by the Corral, J., Lavenir, I., Impey, H., Warren, A.J., Forster, A., Larson,
Taplin Biological Mass Spectrometry Facility at the Harvard Medi- T.A., Bell, S., McKenzie, A.N., King, G., and Rabbitts, T.H. (1996).
cal School. An Mll-AF9 fusion gene made by homologous recombination causes
acute leukemia in chimeric mice: a method to create fusion onco-
Recombinant Enzyme and Edman Degradation Analysis genes. Cell 85, 853–861.
His-tagged Taspase1 was expressed in BL21(DE3) cells and purified Dash, A., and Gilliland, D.G. (2001). Molecular genetics of acute
with a TALON column (Clontech). N-terminal protein sequencing myeloid leukaemia. Best Pract. Res. Clin. Haematol. 14, 49–64.
was performed by Molecular Biology Core Facility at the Dana-
Domer, P.H., Fakharzadeh, S.S., Chen, C.S., Jockel, J., Johansen,Farber Cancer Institute.
L., Silverman, G.A., Kersey, J.H., and Korsmeyer, S.J. (1993). Acute
mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fu-RNAi, Reverse Transcription, and Quantitative PCR
sion product. Proc. Natl. Acad. Sci. USA 90, 7884–7888.HeLa cells were transfected with indicated duplex RNAi (Dhar-
Downing, J.R., and Look, A.T. (1996). MLL fusion genes in the 11q23macon) using oligofectamine (Invitrogen). Double-stranded ribooli-
acute leukemias. Cancer Treat. Res. 84, 73–92.gonucleotides with overhanging 3	 deoxy TT were prepared to target
mRNAs of either hTaspase1 (GACUCACAUUUCAAGACUU) or hMLL Ernst, P., Wang, J., Huang, M., Goodman, R.H., and Korsmeyer, S.J.
(GAAGUCAGAGUGCGAAGUC). Cells harvested 72 hr after transfec- (2001). MLL and CREB bind cooperatively to the nuclear coactivator
tion were either lysed in RIPA buffer for immunoblots or with Trizol CREB-binding protein. Mol. Cell. Biol. 21, 2249–2258.
(Invitrogen) for RNA purification using RNeasy (Qiagen). Transfection
Fair, K., Anderson, M., Bulanova, E., Mi, H., Tropschug, M., and
of p75 wt MLL reporter substrate was performed 48 hr following
Diaz, M.O. (2001). Protein interactions of the MLL PHD fingers modu-
individual RNAi knockdown in HeLa cells and the cellular extracts
late MLL target gene regulation in human cells. Mol. Cell. Biol. 21,
were harvested 24 hr later for immunoblot analysis. Reverse tran-
3589–3597.
scription were performed with oligo-dT primers using Superscript
Forster, A., Pannell, R., Drynan, L.F., McCormack, M., Collins, E.C.,II (Invitrogen). Quantitative PCR was performed in triplicate using
Daser, A., and Rabbitts, T.H. (2003). Engineering de novo reciprocalindicated gene specific primers (Supplemental Data available at Cell
chromosomal translocations associated with Mll to replicate primarywebsite) with SYBR green (PE biosystems) on the ABI Prism 7700
events of human cancer. Cancer Cell 3, 449–458.sequence detection system.
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